LY-3177833
A potent and selective CDC7 inhibitor with IC50 of 3.3 nM. (In Vitro) :LY3177833 (10 μM; 4 days) increases SA-β-gal content in Hep3B cells. (In Vivo) :LY3177833 (Example 4; 10.4-31.2 mg/kg; oral gavage; twice a day; for 2 weeks; female athymic Balb/c nude mice with SW620 cells) treatment causes significant tumor regression in a dose-dependent manner. Also, no significant tumor growth is observed for 2 weeks after dosing cessation.
Product Specifications
CAS Number
1627696-51-8
Product Name Alternative
LY3177833
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 30 mg/mL
Smiles
O=C1N[C@@] (C) (C2=NC=NC=C2F) C3=C1C=C (C4=CNN=C4) C=C3
Molecular Formula
C16H12FN5O
Molecular Weight
309.2978
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1H-Isoindol-1-one, 3- (5-fluoro-4-pyrimidinyl) -2,3-dihydro-3-methyl-6- (1H-pyrazol-4-yl) -, (3R) -
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
COVID-19 TaqMan RT-PCR Kit (N/ORF1ab genes) -50p
Amylin (IAPP) (NM_000415) Human Over-expression Lysate
